SCHEMBL3561618

SCHEMBL3561618

C=CCC1(NCc2ccc(OC)cc2)CCC(=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
USP2 O75604 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
TSHR P16473 2/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
ALOX12 P18054 1/20 0.42
PKM P14618 2/20 0.38
MAPT P10636 2/20 0.38
KCNA3 P22001 1/20 0.37
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
HTT P42858 3/20 0.37
GAA P10253 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 1/20 0.36
DPP7 Q9UHL4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3570132 0.82 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2MEN1KMT2AGAA
SCHEMBL3566617 0.80 ALDH1A1 (0.45) ALDH1A1USP2SMN1; SMN2TSHRTP53
SCHEMBL1702302 0.80 HTT (0.48) ALDH1A1USP2SMN1; SMN2MAPTKCNA3
SCHEMBL11091179 0.72 KCNA3 (0.41) ALDH1A1USP2KCNA3HTTGAA
SCHEMBL27143563 0.70 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2PKMMAPTNPC1
SCHEMBL5577604 0.68 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2TSHRTP53CYP3A4
SCHEMBL22486381 0.68 ALDH1A1 (0.40) ALDH1A1USP2SMN1; SMN2TSHRTP53
SCHEMBL22468847 0.68 ALDH1A1 (0.40) ALDH1A1USP2SMN1; SMN2TSHRTP53
SCHEMBL13182882 0.67 ALDH1A1 (0.57) ALDH1A1USP2SMN1; SMN2TSHRTP53
SCHEMBL6616231 0.67 PKM (0.61) ALDH1A1SMN1; SMN2PKMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121689-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-07-31 EP disclosed
US-8404740-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2013-03-26 US disclosed
US-20100048554-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US disclosed
EP-2121689-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2009-11-25 EP disclosed
WO-2008101659-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048554-A1 Spirocyclic Cyclohexane Compounds OPRL1, OPRD1, OPRK1 ALDH1A1 588/4885USP2 4471/4885SMN1; SMN2 2282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.